2nd ICBE Speakers

Keynote Speakers:

  • Jay Keasling, Chief Executive, Joint BioEnergy Institute, University of California, Berkeley. "Synthetic Biology in Pursuit of Low-Cost, Effective, Anti-Malarial Drugs."
  • Peter Schultz, Scripps Professor of Chemistry, The Scripps Institute, and Institute Director of the Genomics Institute of the Novartis Research Foundation. "An Expanding Genetic Code."
  • James Wells, Harry William and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences,  University of California, San Francisco. "Engineering Cell to Death."

Invited, confirmed speakers include:

  • Frances Arnold, California Institute of Technology. "Engineering by Evolution."
  • Jon Clardy, Harvard University. "Insect-Bacteria Mutualisms as a Discovery Engine."
  • Steve DelCardayre, LS9. "Renewable Petroleum ™ Products and Technologies: low cost fuel and chemical substitutes."
  • John Desjarlais, Xencor. "Engineering Antibodies for Enhanced Effector Function, Pharmacokinetics and Low Immunogenicity."
  • Andrew Ellington, University of Texas, Austin.  "In vitro evolution of synthetic circuits."
  • Klaus Hahn, University of North Carolina at Chapel Hill. "New Tools to Visualize and Manipulate Signaling in Living Cells."
  • Sang Yup Lee, Korea Advanced Institute of Science and Technology. " Metabolic and cellular engineering for the production of chemicals and materials."
  • Stephen Michnick, University of Montreal. "The Dark Matter of Protein Interaction Networks."
  • Bernhard Palsson, University of California, San Diego, "Reconstruction of the genome-scale human metabolic network based on build-35 and bibliomic data."
  • Andreas Plückthun, University of Zürich. "The Taming of the Shrew: Improving GPCR Expression and Stability."
  • Uwe Sauer, ETH Zurich. "Unraveling Condition-Specific Networks of Active Metabolic Regulation."
  • Gideon Schreiber, Weizmann Institute of Science. "Computer based design for affinity and specificity of protein-protein interactions."
  • James Swartz, Stanford University, "Custom-Designed Viral Mimics as Vaccines and Delivery Vehicles."
  • Bruce Tidor, Massachusetts Institute of Technology. "Molecular and Network Modeling in Synthetic and Systems Biology."
  • Stefan Wildt, Merck. "Genetic and metabolic engineering of the methylotrophic yeast P. pastoris as a host for therapeutic protein production."